000 01417 a2200397 4500
005 20250512020436.0
264 0 _c19890706
008 198907s 0 0 eng d
022 _a0001-5598
024 7 _a10.1530/acta.0.1200602
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLai, K N
245 0 0 _aT lymphocyte activation in euthyroid Graves' ophthalmopathy: soluble interleukin 2 receptor release, cellular interleukin 2 receptor expression and interleukin 2 production.
_h[electronic resource]
260 _bActa endocrinologica
_cMay 1989
300 _a602-9 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aCarbimazole
_xadministration & dosage
650 0 4 _aCells, Cultured
650 0 4 _aFemale
650 0 4 _aGraves Disease
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aInterleukin-2
_xbiosynthesis
650 0 4 _aLymphocyte Activation
_xdrug effects
650 0 4 _aMale
650 0 4 _aMitogens
_xpharmacology
650 0 4 _aRadioimmunoassay
650 0 4 _aReceptors, Interleukin-2
_xbiosynthesis
650 0 4 _aT-Lymphocytes
_ximmunology
700 1 _aLeung, J C
700 1 _aChow, C C
700 1 _aCockram, C S
773 0 _tActa endocrinologica
_gvol. 120
_gno. 5
_gp. 602-9
856 4 0 _uhttps://doi.org/10.1530/acta.0.1200602
_zAvailable from publisher's website
999 _c2792169
_d2792169